Multidisciplinary health monitoring program for patients with Obstructive Sleep Apnea undergoing CPAP treatment.

Not Applicable

• Conditions: Obstructive Sleep Apnea (OSA)

• Registration Number: RBR-9f4f5dc
• Lead Sponsor: niversidade Federal de Lavras

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-10-05
• Study Completion: 2022-12-01
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruitment completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

The study will include all patients diagnosed with OSA of any severity, participating in the Oxygen Therapy and Mechanical Ventilation Program in the municipality of Lavras during the study period that accepts to participate in the study.

Exclusion Criteria

The study will not include people who refuse to participate in the evaluations or proposed interventions, people who are involved in other programs that aim to weight loss or nutritional monitoring, with other sleep disorders, such as insomnia, restless legs syndrome or narcolepsy, shift workers nocturnal. In addition to the above, patients using large doses of probiotics will not be included commercial products consumed in the last 6 months (greater than or equal to 10^8 CFU or organisms perday) - includes tablets, capsules, lozenges, chewing gums or powders in which the probiotic is a primary component (must be discontinued and avoided for one month before the start of
study).

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction in the serum concentration of C-reactive protein (hs-PCR), determined by quantification in a blood sample. Data will be collected before the beginning and at the end of each stage of the study. Therefore, data will be collected at the initial time (before supplementation – t0), after the completion of the first supplementation phase at 3 months (t3) and at the end of the second supplementation phase, at six months (t6). The data obtained will be analyzed comparing the results: (i) intragroup, (ii) intergroup and (iii) group vs time.<br>